Format
Sort by
Items per page

Send to

Choose Destination

Best matches for liver cirrhosis nutrition:

Nutrition in cirrhosis and chronic liver disease. Juakiem W et al. Clin Liver Dis. (2014)

Nutrition and exercise in the management of liver cirrhosis. Toshikuni N et al. World J Gastroenterol. (2014)

Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis. Nishikawa H et al. Mediators Inflamm. (2015)

Search results

Items: 1 to 20 of 2635

1.

Preoperative optimization for major hepatic resection.

Walcott-Sapp S, Billingsley KG.

Langenbecks Arch Surg. 2017 Nov 18. doi: 10.1007/s00423-017-1638-x. [Epub ahead of print] Review.

PMID:
29150719
2.

Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study.

Rogal SS, Udawatta V, Akpan I, Moghe A, Chidi A, Shetty A, Szigethy E, Bielefeldt K, DiMartini A.

PLoS One. 2017 Nov 17;12(11):e0187176. doi: 10.1371/journal.pone.0187176. eCollection 2017.

PMID:
29149171
3.

Tricho-hepato-enteric syndrome with novel SKIV2L gene mutations: A case report.

Hiejima E, Yasumi T, Nakase H, Matsuura M, Honzawa Y, Higuchi H, Okafuji I, Yorifuji T, Tanaka T, Izawa K, Kawai T, Nishikomori R, Heike T.

Medicine (Baltimore). 2017 Nov;96(46):e8601. doi: 10.1097/MD.0000000000008601.

PMID:
29145277
4.

Liver protective effects of extra virgin olive oil: interaction between its chemical composition and the cell-signaling pathways involved in protection.

Soto-Alarcon SA, Valenzuela R, Valenzuela A, Videla LA.

Endocr Metab Immune Disord Drug Targets. 2017 Nov 14. doi: 10.2174/1871530317666171114120552. [Epub ahead of print]

PMID:
29141573
5.

Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury.

Wan Y, McDaniel K, Wu N, Ramos-Lorenzo S, Glaser T, Venter J, Francis H, Kennedy L, Sato K, Zhou T, Kyritsi K, Huang Q, Annable T, Wu C, Glaser S, Alpini G, Meng F.

Am J Pathol. 2017 Nov 2. pii: S0002-9440(17)30583-7. doi: 10.1016/j.ajpath.2017.08.027. [Epub ahead of print]

PMID:
29128099
6.

The Genetics of Pediatric Nonalcoholic Fatty Liver Disease.

Goyal NP, Schwimmer JB.

Clin Liver Dis. 2018 Feb;22(1):59-71. doi: 10.1016/j.cld.2017.08.002. Epub 2017 Oct 5. Review.

PMID:
29128061
7.

Changes in liver function and body composition by direct-acting antiviral therapy for hepatitis C virus infection.

Sugimoto R, Iwasa M, Hara N, Tamai Y, Yoshikawa K, Ogura S, Tanaka H, Eguchi A, Yamamoto N, Kobayashi Y, Hasegawa H, Takei Y.

Hepatol Res. 2017 Nov 8. doi: 10.1111/hepr.12999. [Epub ahead of print]

PMID:
29115717
8.

Therapeutic Effects of Curcumin on Ultrasonic Morphological Characteristics of Liver in Patients with Metabolic Syndrome.

Selmanovic S, Beganlic A, Salihefendic N, Ljuca F, Softic A, Smajic E.

Acta Inform Med. 2017 Sep;25(3):169-174. doi: 10.5455/aim.2017.25.169-174.

9.

Pyroptosis by Caspase11/4-Gasdermin-D Pathway in Alcoholic Hepatitis.

Khanova E, Wu R, Wang W, Yan R, Chen Y, French SW, Llorente C, Pan SQ, Yang Q, Li Y, Lazaro R, Ansong C, Smith RD, Bataller R, Morgan T, Schnabl B, Tsukamoto H.

Hepatology. 2017 Nov 6. doi: 10.1002/hep.29645. [Epub ahead of print]

PMID:
29108122
10.

Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease.

Riva A, Patel V, Kurioka A, Jeffery HC, Wright G, Tarff S, Shawcross D, Ryan JM, Evans A, Azarian S, Bajaj JS, Fagan A, Patel V, Mehta K, Lopez C, Simonova M, Katzarov K, Hadzhiolova T, Pavlova S, Wendon JA, Htun Oo Y, Klenerman P, Williams R, Chokshi S.

Gut. 2017 Nov 2. pii: gutjnl-2017-314458. doi: 10.1136/gutjnl-2017-314458. [Epub ahead of print]

11.

Steatosis and NASH in type 2 diabetes.

Hu M, Phan F, Bourron O, Ferré P, Foufelle F.

Biochimie. 2017 Oct 31. pii: S0300-9084(17)30271-7. doi: 10.1016/j.biochi.2017.10.019. [Epub ahead of print]

PMID:
29097281
12.

Etiology and mode of presentation of chronic liver diseases in India: A multi centric study.

Mukherjee PS, Vishnubhatla S, Amarapurkar DN, Das K, Sood A, Chawla YK, Eapen CE, Boddu P, Thomas V, Varshney S, Hidangmayum DS, Bhaumik P, Thakur B, Acharya SK, Chowdhury A.

PLoS One. 2017 Oct 26;12(10):e0187033. doi: 10.1371/journal.pone.0187033. eCollection 2017.

13.

Nutrition and the transplant candidate.

Mazurak VC, Tandon P, Montano-Loza AJ.

Liver Transpl. 2017 Nov;23(11):1451-1464. doi: 10.1002/lt.24848. Review.

PMID:
29072825
14.

Characterization of body composition and definition of sarcopenia in patients with alcoholic cirrhosis: A computed tomography based study.

Benjamin J, Shasthry V, Kaal CR, Anand L, Bhardwaj A, Pandit V, Arora A, Rajesh S, Pamecha V, Jain V, Kumar G, Loria A, Puri P, Joshi YK, Sarin SK.

Liver Int. 2017 Nov;37(11):1668-1674. doi: 10.1111/liv.13509. Epub 2017 Jul 29.

PMID:
29065258
15.

Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper.

Antonucci L, Porcu C, Iannucci G, Balsano C, Barbaro B.

Nutrients. 2017 Oct 18;9(10). pii: E1137. doi: 10.3390/nu9101137. Review.

16.

Vitamin A status and its determinants in patients with cystic fibrosis.

Sapiejka E, Krzyżanowska P, Walkowiak D, Wenska-Chyży E, Szczepanik M, Cofta S, Pogorzelski A, Skorupa W, Walkowiak J.

Acta Sci Pol Technol Aliment. 2017 Jul-Sep;16(3):345-354. doi: 10.17306/J.AFS.0473.

PMID:
29055982
17.

Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus.

Llorente C, Jepsen P, Inamine T, Wang L, Bluemel S, Wang HJ, Loomba R, Bajaj JS, Schubert ML, Sikaroodi M, Gillevet PM, Xu J, Kisseleva T, Ho SB, DePew J, Du X, Sørensen HT, Vilstrup H, Nelson KE, Brenner DA, Fouts DE, Schnabl B.

Nat Commun. 2017 Oct 16;8(1):837. doi: 10.1038/s41467-017-00796-x.

18.

Hyperammonemia and proteostasis in cirrhosis.

Dasarathy S, Hatzoglou M.

Curr Opin Clin Nutr Metab Care. 2017 Oct 14. doi: 10.1097/MCO.0000000000000426. [Epub ahead of print]

PMID:
29035972
19.

Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis.

Perumpail BJ, Li AA, Cholankeril G, Kumari R, Ahmed A.

Nutrients. 2017 Oct 13;9(10). pii: E1114. doi: 10.3390/nu9101114. Review.

20.

Exercise and physical activity for patients with ESLD: Improving functional status and sarcopenia while on the transplant waitlist.

Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ, Macías-Rodríguez R, Ferrando A, Kim WR.

Liver Transpl. 2017 Oct 11. doi: 10.1002/lt.24958. [Epub ahead of print] Review.

PMID:
29024353

Supplemental Content

Loading ...
Support Center